Samsung Pharm
Pancreatic cancer treatment is gaining popularity because of clinical results.
It's dangerous because its power is almost gone.
Still, it looks good for a quick-witted single hit with a lot of trading volume.
As short selling is a little off, we are looking at it positively.
The results of the pancreatic cancer treatment drug Riavax were announced on 6/4 of the American Clinical Association.
If it is done there, I think there will be no meaningful results.
But once it starts to break, it can plummet, so if it lights up slightly blue, you need a knife-like hand loss.
Goo Young Tech
On a daily basis, it looks normal.
Its market cap is about 110 billion won, and its strength is still left as it moves sideways above the moving average.
주봉을 보게되면 저점횡보후 -> 급등 -> 절반하락후 횡보 -> 2차 잔파동 상승수렴 마지막
This is a common stock pattern.
Shares related to automobiles, Hyundai Motors, and Ioniq 5.
As the automobile industry is showing a continuous boom, the performance looks good.
Woojin
It showed a decline while raising the upper tail, but it seems that the strength is still there.
Because it showed a steady upward trend.
Since the Korea-US summit, nuclear power is slowly rising again.
In fact, since Korea's nuclear power technology is world-class, if the government provides a little support, it will be restored quickly.
This time, Doosan Heavy Industries & Construction also showed a good figure with the theme of nuclear power plant, and is taking Ujin with a circular falcon.
Other news
Shinyoung spec: It's not over yet.. spec anomaly
Next Science: Vietnam Vaccine Nanogen Related Shares
Hanil Vacuum: Humanigen Corona treatment related
Jinheung Enterprise: Sale of management rights
Samsung Publisher: Elon Musk tweets baby shark
COAS, Korea Cement: Yoon Seok-Yeol's reconstruction policy is being prepared
A Plus Asset: Naver enters insurance business
KCity: Chinese digital currency CBDC related stocks
